Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.

Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that Aetna Healthcare has authorized a claim for reimbursement for ...

Helius Medical Technologies (NASDAQ:HSDT) shares are trading higher Wednesday after the company announced an authorized claim ...

At the heart of the contract dispute is a disagreement over reimbursement rates ... Health & Services Oregon ended its contract with Aetna, while Salem Health dropped Regence BlueCross BlueShield ...

The service covers the ecosystem of Huawei devices, from smartphones and laptops to wearables and audio products, ensuring users can enjoy their Huawei devices with an unprecedented level of ...

Wearable devices such as fitness trackers and smartwatches can help people with primary progressive multiple sclerosis manage symptoms, track their activity, and improve their overall health.

The PoNS device’s use is limited to individuals 22 years and older with mild-to-moderate symptoms, potentially excluding a significant portion of the MS population and limiting market reach.